The KEYNOTE-028 study (NCT02054806) enrolled patients with PD-L1 positive, well- or moderately differentiated pancreatic neuroendocrine tumor (n = 16) or carcinoid tumor (n = 25 of which nine were PCs) (31). The gene discussed is CD274; the disease is pancreatic neuroendocrine tumor.